Cytokines and glial cells

The interaction between cytokines and glial cells represents a broad biological signaling network rather than a single therapeutic target. Glial cells, including microglia and astrocytes, are the primary immune effectors of the central nervous system (CNS), producing and responding to various cytokines to regulate neuroinflammation and maintain neuronal health (Source: PubMed, PMID: 30033924). In pathological states such as Alzheimer's disease or multiple sclerosis, dysregulated cytokine production leads to chronic glial activation, which contributes to neurodegeneration and synaptic loss (Source: Nature Reviews Neurology, 2020). While specific cytokines like TNF-alpha or IL-1 beta are valid drug targets, the grouping 'Cytokines and glial cells' encompasses a vast array of distinct molecular interactions across different cell types. Therapeutic strategies often focus on modulating this axis to dampen neuroinflammation, though challenges remain regarding blood-brain barrier penetration and the dual neuroprotective/neurotoxic roles of glial cells (Source: Frontiers in Cellular Neuroscience, 2019). Consequently, this entry is considered incorrect as a specific target because it lacks the molecular specificity required for drug development (Source: StatPearls, 2023).

Other names

Neuroinflammatory axisGlia-cytokine signalingNeuroimmune systemGlial-derived cytokines

Modulation of neuroinflammatory signaling by inhibiting specific pro-inflammatory cytokines or suppressing glial cell activation.